Accelerate Device Innovation with Regulatory-Ready AI
Getting a medical device to market takes 3-7 years and costs $31M on average. We build AI that automates regulatory documentation, predicts quality issues before they become recalls, and turns post-market surveillance into a competitive advantage.
The Medical Device Innovation Bottleneck
Regulatory burden, quality system complexity, and post-market requirements slow down even the most innovative device companies.
Regulatory Submission Overload
510(k) and PMA submissions require thousands of pages of documentation. Manual preparation consumes months of engineering time.
Manufacturing Quality Variability
Process deviations cause costly scrap, rework, and delays. Traditional SPC methods miss subtle drift patterns.
Complaint & CAPA Management
FDA expects timely complaint investigation and CAPA implementation. Manual processes lead to backlog and regulatory risk.
Post-Market Surveillance Gaps
MDR and IVDR require active post-market surveillance, but most teams rely on reactive complaint analysis.
Design History File Complexity
DHF documentation for FDA and EU MDR requires traceability from user needs to verification. Maintaining this manually is error-prone.
Supply Chain Disruption
Component shortages and supplier quality issues require rapid qualification of alternates without compromising regulatory status.
AI for the Full Device Lifecycle
From design controls to post-market surveillance, our AI solutions understand the unique requirements of regulated medical devices.
Cut Your Regulatory Timelines in Half
See how AI-powered document automation and quality analytics can accelerate your next submission.
Results from Class II Device Manufacturers
Composite metrics from medical device clients ranging from startups to mid-cap manufacturers.
Where Device Makers See Value
Three areas where AI delivers the highest impact in regulated device environments.
Regulatory Framework Alignment
Our AI tools are built with medical device regulations embedded into every workflow.
Why Device Companies Trust OpenMalo
We understand that in medical devices, AI is not just about efficiency — it is about patient safety.
Get a Regulatory AI Assessment
Tell us about your device portfolio and we will identify the highest-impact AI opportunities.
Device Maker Success
Class II Manufacturer Cuts Submission Time 45%
A mid-size cardiovascular device company automated 510(k) preparation and deployed predictive quality monitoring across two manufacturing sites.
The Problem
Regulatory submissions were consuming 40% of engineering capacity while manufacturing quality issues led to two voluntary recalls in 18 months.
Our Approach: We deployed document intelligence AI to auto-draft 510(k) sections from existing design files, implemented predictive quality models on manufacturing data, and built an automated CAPA workflow that reduced cycle time from 90 days to 35 days on average.
Read Full Case StudyWhat Our Clients Say
“The AI drafted our predicate comparison in two days. It used to take our regulatory team three weeks. And it was more thorough.
“We caught a sterilization drift pattern six hours before it would have affected a production batch. That alone paid for the entire year.
“Our FDA audit went smoother than any in company history. The auditor commented on the quality of our documentation and traceability.
Frequently Asked Questions
Yes, with proper validation. Our AI tools include validation protocols compliant with FDA guidance on AI/ML in medical devices. We provide all documentation needed for design history files and regulatory submissions.
Explore Related Industries
Discover how we serve similar verticals with tailored technology solutions and deep domain expertise.
